The German national registry for primary immunodeficiencies (PID)

…, T Rothoeft, R Krüger, EC Scharbatke… - Clinical & …, 2013 - academic.oup.com
… To gain knowledge about the natural history and approximate the prevalence of PID, it is
mandatory to collect patient data in central electronic patient registries. During the past 20 years…

Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study

…, P Roll, EC Scharbatke, E Ostermeier… - Rheumatology …, 2012 - Springer
The objective of this study is to evaluate the vaccination status in rheumatoid arthritis (RA)
patients during routine clinical practice, data from a German non-interventional cross-sectional …

Does concomitant methotrexate with adalimumab influence treatment outcomes in patients with psoriatic arthritis? Data from a large observational study

…, BM Wittig, G Greger, D Thaçi, E Scharbatke… - The Journal of …, 2016 - jrheum.org
Objective. To examine the influence of concomitant methotrexate (MTX) with adalimumab (ADA)
on outcomes in patients with psoriatic arthritis (PsA) using data from an observational …

Development and validation of a new Disease Activity Score in 28 joints–based treatment response criterion for rheumatoid arthritis

…, R Alten, S Kleinert, EC Scharbatke… - Arthritis Care & …, 2013 - Wiley Online Library
Scharbatke has received consultant fees, speaking fees, and/or honoraria (less than
$10,000) from Abbott. Dr. Gnann has received consultant fees (less than $10,000) from AbbVie. …

[PDF][PDF] Association of improvement in pain with therapeutic response as determined by individual improvement criteria in patients with rheumatoid arthritis

EC Scharbatke, F Behrens, M Schmalzing… - Arthritis Care & …, 2016 - Wiley Online Library
Objective To use statistical methods to establish a threshold for individual response in
patient‐reported outcomes (PROs) in patients with rheumatoid arthritis. Methods We used an …

Anti-CCP status determines the power Doppler oscillation pattern in rheumatoid arthritis: a prospective study

…, T Wech, S Schuh, E Scharbatke, E Ostermeier… - Rheumatology …, 2016 - Springer
Rheumatoid arthritis (RA) is a chronic inflammatory disease leading to joint destruction.
Serologically, it can be differentiated according to rheumatoid factor (RF), anti-cyclic citrullinated …

[PDF][PDF] The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis

…, S Kleinert, EC Scharbatke… - Clin Exp …, 2015 - clinexprheumatol.org
… Martin Feuchtenberger, MD Stefan Kleinert, MD Eva-Christina Scharbatke, MD Holger
Gnann, Dipl-Stat Frank Behrens, MD Bianca M Wittig, MD Gerd Greger, PhD Hans-Peter …

SAT0358 Impact of Methotrexate on Anti-TNF Treatment in Psoriatic Arthritis? an In-Depth Analysis of A Large Prospective Observational Study with Adalimumab

…, B Wittig, G Greger, D Thaci, E Scharbatke… - Annals of the …, 2014 - ard.bmj.com
Background In active psoriatic arthritis (PsA) the efficacy of TNF-inhibitors (TNFi) has been
proven in randomized clinical trials (RCT). Methotrexate (MTX) co-medication can improve …

[HTML][HTML] Treatment of congenital microgastria

…, SMBI Botden, HE Daniels-Scharbatke… - European Journal of …, 2021 - thieme-connect.com
Introduction Congenital microgastria is an extremely rare birth defect. The aim of this study
was to present an overview of existing literature on the treatment of microgastria. Materials …

SAT0070 Association of Improvement in Pain with Therapeutic Response as Determined by Individual Significant Improvement Criteria in Patients with Rheumatoid …

E Scharbatke, F Behrens, M Schmalzing, M Koehm… - 2015 - ard.bmj.com
Background Patient-reported outcomes (PRO) provide an important perspective on patient9s
perception of their clinical well-being. A better understanding of the association between …